XDJP:XETRA:XETRA-Xtrackers Nikkei 225 UCITS ETF 1D (EUR)

ETF | Others |

Last Closing

USD 24.73

Change

0.00 (0.00)%

Market Cap

USD 157.79B

Volume

0.07M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-31 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.08 (+0.17%)

USD 502.95B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.02 (+0.14%)

USD 191.96B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.05 (+0.18%)

USD 177.46B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.06 (+0.21%)

USD 177.46B
JARI:XETRA Amundi Index Solutions - Amund..

+0.03 (+0.05%)

USD 102.11B
8R80:XETRA Amundi Index Solutions - Amund..

-1.24 (-0.89%)

USD 102.11B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.08 (+0.16%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+4.10 (+0.77%)

USD 80.38B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.04 (+0.15%)

USD 79.79B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.68 (+0.73%)

USD 72.04B

ETFs Containing XDJP:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.88% 69% C- 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.88% 69% C- 71% C-
Trailing 12 Months  
Capital Gain 16.19% 66% D+ 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.19% 66% D+ 68% D+
Trailing 5 Years  
Capital Gain 35.67% 53% F 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 35.67% 53% F 59% D-
Average Annual (5 Year Horizon)  
Capital Gain 14.64% N/A N/A 84% B
Dividend Return 15.08% N/A N/A 83% B
Total Return 0.44% N/A N/A 23% F
Risk Return Profile  
Volatility (Standard Deviation) 340.48% N/A N/A 1% F
Risk Adjusted Return 4.43% N/A N/A 29% F
Market Capitalization 157.79B 100% F 98% N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:

There is nothing we particularly dislike